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 Abstract  Non-alcoholic steatohepatitis (NASH) is closely associated with 
 progression to liver cirrhosis and hepatocellular carcinoma. We reported that 
 melanocortin 4 receptor–defi cient mice (MC4R-KO mice), when fed a high-fat diet, 
provide a novel rodent model of NASH. Recently, we have identifi ed a unique 
 histological feature termed “hepatic crown-like structures” (hCLS) in the livers of 
MC4R-KO mice and NASH patients. In hCLS, CD11c-positive macrophages 
aggregate to surround hepatocytes with large lipid droplets, similar to the “crown-
like structure (CLS)” described in obese adipose tissue. Interestingly, we have 
recently reported that macrophage-induced C-type lectin (Mincle) is involved in 
CLS formation and fi brogenic gene expression in obese adipose tissue, suggesting 
the pathophysiologic role of CLS in obesity-induced adipose tissue fi brosis. 
Collectively, our data provide evidence that hCLS serves as an origin of hepatic 
infl ammation and fi brosis during the progression from simple steatosis to NASH 
and thus helps in elucidation of the pathogenesis of NASH, pursuit of specifi c bio-
markers, and evaluation of potential therapeutic strategies. 
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 Introduction 
 The metabolic syndrome is defi ned as a combination of visceral fat obesity, impaired 
glucose metabolism, atherogenic dyslipidemia, and blood pressure elevation, all of 
which are independent risk factors for atherosclerotic diseases. The molecular basis 
for the clustering of such independent risks of atherosclerosis is not currently 
unclear, with visceral fat obesity considered most important. There is considerable 
evidence that lifestyle diseases are a tissue-remodeling disease. Indeed, obese 
 adipose tissue is characterized by adipocyte hypertrophy, increased angiogenesis 
and infi ltration of immune cells such as macrophages and lymphocytes, tissue 
 fi brosis, and increased production of proinfl ammatory adipokines [ 1 ]. The  functional 
and morphological changes observed in obese adipose tissue are very similar to 
those described in vascular remodeling during the process of atherosclerosis. We 
have called the dynamic changes in obese adipose tissue “adipose tissue remodeling” 
and have been interested in the molecular basis underlying adipose tissue remodel-
ing and its pathophysiological implication in metabolic diseases. 
 Interaction Between Adipocytes and Macrophages 
in Obese Adipose Tissue 
 We and others previously reported that during the progression from visceral fat 
obesity to a variety of lifestyle diseases, hypertrophied adipocytes can secrete a 
number of cytokines and chemokines such as monocyte chemoattractant protein-1 
(MCP-1) to stimulate the recruitment of C-C chemokine receptor type 2 (CCR2)-
positive monocytes into obese adipose tissue as proinfl ammatory M1 macrophages. 
Once infi ltrated, macrophages may be activated in response to saturated fatty acids 
released from hypertrophied adipocytes and produce a large amount of proinfl amma-
tory cytokines such as tumor necrosis factor-α (TNF-α), which, in turn, augments 
the infl ammatory response and adipocyte lipolysis to increase the release of fatty 
acids in hypertrophied adipocytes. These observations led us to speculate that there 
is an intimate crosstalk between parenchymal cells, adipocytes, stromal cells, and 
macrophages, which establishes a vicious cycle that augments obesity-induced 
 adipose tissue infl ammation [ 2 ,  3 ]. Our data also suggest that saturated fatty acids 
serve as a naturally occurring ligand for Toll-like receptor 4 (TLR4) complex, a 
well-known pathogen sensor expressed in infi ltrating macrophages [ 3 ]. 
 As the site of crosstalk between adipocytes and macrophages, there is a unique 
histological feature termed a “crown-like structure” (CLS) in obese adipose tissue 
[ 4 ], which is composed of dead parenchymal adipocytes surrounded by  macrophages. 
In CLS, macrophages are considered to scavenge the residual lipid droplets of dead 
or dying adipocytes. It is likely that the adipocyte–macrophage interaction can 
 stimulate adipocyte lipolysis and thus increase the release of free fatty acids, par-
ticularly saturated fatty acids, from obese adipose tissue, which may be  accumulated 
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in non-adipose tissue as ectopic fat, thereby inducing a variety of metabolic effects 
called lipotoxicity [ 5 ]. 
 Development of a Novel Rodent Model of NASH 
 Non-alcoholic fatty liver disease (NAFLD) is defi ned as increased accumulation of 
lipids in the liver without a history of excess alcohol consumption. It is considered 
the hepatic manifestation of the metabolic syndrome. Non-alcoholic steatohepatitis 
(NASH), the most aggressive subset of NAFLD, is closely associated with the 
development of liver cirrhosis and hepatocellular carcinoma. The pathogenesis of 
NASH, the well-known “two-hit hypothesis”, has been proposed for many years; 
however, the detailed mechanism of disease progression from simple steatosis to 
NASH is currently unclear, partly because there are no appropriate animal models 
that refl ect the liver condition of human NASH and partly because liver biopsy is 
required for its defi nite diagnosis. 
 Melanocortin-4 receptor (MC4R) is a seven-transmembrane G protein-coupled 
receptor that is expressed in the hypothalamic nuclei implicated in the regulation of 
food intake and body weight. Its pathogenic mutations are the most common known 
monogenic cause of human obesity. We recently reported that MC4R-defi cient 
(MC4R-KO) mice develop a liver condition similar to human NASH when fed a 
high-fat diet (HFD) or a Western diet (WD), which is associated with obesity,  insulin 
resistance, and dyslipidemia [ 6 ]. Notably, they exhibited enhanced adipose tissue 
infl ammation, which may contribute to excessive lipid accumulation and enhanced 
fi brosis in the liver. Moreover, they developed well-differentiated HCC for a 
 prolonged time. Our data suggest that MC4R-KO mice would provide a novel 
rodent model of NASH with which to investigate the sequence of events that 
encompass diet-induced obesity, hepatic steatosis, liver fi brosis, and HCC.
Histologically, they showed hepatocyte ballooning degeneration, increased infi ltra-
tion of  infl ammatory cells such as macrophages and lymphocytes, and pericellular 
fi brosis, all of which are hallmarks of human NASH. Immunohistochemical stain-
ing with α-smooth muscle action (αSMA) revealed that hepatic stellate cells are 
activated in the liver from MC4R-KO mice even before the onset of fi brosis. 
 Identifi cation of Hepatic Crown-Like Structure (hCLS) 
 During the course of obesity, MC4R-KO mice developed a number of CLS in the 
adipose tissue. We found bizarre microstructures in livers from MC4R-KO mice, 
which are very similar to CLS in obese adipose tissue [ 7 ]. We have called them 
“hepatic crown-like structures” (hCLS), where macrophages aggregate to surround 
hepatocytes with large lipid droplets. Although there was no signifi cant difference 
in the number of F4/80-positive macrophages between the genotypes, the number of 
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hCLS was increased in MC4R-KO mice relative to wild-type mice, suggesting that 
the distribution of macrophages was altered in the livers from MC4R-KO mice. 
Importantly, there was a signifi cant correlation between the number of hCLS and 
the extent of liver fi brosis. These observations, taken together, suggest that hCLS 
rather than macrophages themselves are associated with the development of liver 
fi brosis during the progression from simple steatosis to NASH. 
 To further explore the functional signifi cance of hCLS in the development of liver 
fi brosis, we depleted macrophages in livers from MC4R-KO mice by the clodronate 
liposome method. In MC4R-KO mice, macrophages scattered in the liver were effec-
tively depleted, although those in hCLS appeared to be intact. Accordingly, treatment 
with clodronate liposome signifi cantly reduced the F4/80-positive areas in the liver 
from MC4R-KO mice. However, there was no signifi cant change in the numbers of 
hCLS and αSMA-positive cells after the treatment. In this setting, treatment with 
clodronate liposome resulted in a signifi cant reduction of expression of infl ammatory 
and fi brogenic genes in the liver from wild-type mice. By contrast, in MC4R-KO 
mice, there was no signifi cant change in the gene expression after the treatment. 
These observations suggest that hCLS macrophages are resistant to the treatment and 
that hCLS is functionally associated with hepatic infl ammation and fi brosis in NASH 
liver. Immunofl uorescence and electron microscopy analyses revealed that hCLS is 
composed of CD11c-positive macrophages and dead parenchymal hepatocytes with 
large lipid droplets, and is spatially associated with αSMA-positive activated stellate 
cells and collagen deposition, which support the notion that hCLS is involved in the 
development of hepatic infl ammation and fi brosis. 
 We also found that hCLS occurs in patients with NASH or even in those with 
simple steatosis in proportion to the extent of liver fi brosis. Importantly, there was 
no such increase in hCLS in patients with chronic viral hepatitis, suggesting that 
hCLS is rather specifi c to metabolic liver diseases. 
 Figure  1 illustrates the role of hCLS in the pathogenesis of NASH. Increased fl ux 
of free fatty acids from visceral adipose tissue to the liver via the portal vein as a 
result of adipose tissue infl ammation can cause simple steatosis. Parenchymal 
 hepatocytes that are being overloaded with lipid and are thus dead or dying are sur-
rounded by macrophages to form hCLS in the fatty liver. In the NASH liver, macro-
phages can interact with and engulf dead hepatocytes within hCLS, thereby activating 
fi brogenic cells to stimulate hepatic fi brosis as an adaptive repair response to tissue 
injury. It is, therefore, likely that hCLS serves as an origin of hepatic infl ammation 
and fi brosis during the progression from simple steatosis to NASH [ 7 ].
 Macrophage-Induced C-Type Lectin (Mincle) 
 Macrophage-induced C-type lectin (Mincle) is a type II transmembrane Ca + -
dependent carbohydrate binding lectin. It is expressed abundantly in macrophages, 
where it is induced in response to LPS. Recent studies show that Mincle is a 
 pathogen sensor that recognizes the mycobacterial glycolipid trehalose dimycolate 
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(TDM) [ 8 ]. More interestingly, it can also recognize an endogenous ligand that is 
released from dead cells as a danger signal [ 9 ]. We previously reported that during 
the interaction between adipocytes and macrophages, saturated fatty acids can 
induce Mincle expression in macrophages through the activation of the TLR4/
nuclear factor κB (NF-κB) pathway [ 10 ]. 
 Mincle mRNA expression is induced in obese adipose tissue, which occurs mostly 
in the stromal vascular fraction. FACS analysis revealed that Mincle is induced in the 
infi ltrating macrophages in obese adipose tissue; a substantial fraction of the macro-
phages is Mincle-positive. By in situ hybridization analysis, we found that Mincle 
mRNA expression is restricted to CLS macrophages in obese adipose tissue. We also 
found that Mincle expression is induced in the adipose tissue of obese humans [ 10 ]. 
There is a signifi cantly positive correlation between Mincle mRNA levels and BMI, 
suggesting the role of Mincle in the pathogenesis of obesity. These observations 
 suggest that Mincle plays a role in adipose tissue remodeling. 
 Role of Mincle in Adipose Tissue Remodeling and Ectopic Fat 
Accumulation 
 To explore the role of Mincle in adipose tissue remodeling in vivo, we examined the 
metabolic phenotype of Mincle-KO mice during the HFD feeding. There was no 
apparent difference in body weight between the genotypes throughout the 
 Fig. 1  Possible role of hCLS during the progression from normal healthy liver and simple steato-
sis to NASH 
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experimental period. At 8 weeks of HFD feeding, when macrophages were not 
 massively infi ltrated, there was no signifi cant difference in adipose tissue and liver 
weight between the genotypes. Notably, at 16 weeks of HFD feeding, when 
 macrophages were massively infi ltrated, Mincle-KO mice showed increased  adipose 
tissue weight with a reciprocal reduction of liver weight. Histological analysis of the 
adipose tissue revealed that adipocytes seemed to be enlarged in Mincle-KO mice in 
response to the HFD feeding. Although there was no signifi cant difference in F4/80-
positive macrophages between the genotypes, the number of CLS was signifi cantly 
reduced in Mincle-KO mice. Since the number of hCLS is more positively  correlated 
with the extent of liver fi brosis than that of macrophages in MC4R-KO mice [ 7 ], we 
examined adipose tissue fi brosis by Masson trichrome staining. There was extensive 
interstitial fi brosis in the epididymal fat depot from wild-type mice, which was 
markedly attenuated in Mincle-KO mice together with a signifi cant reduction of 
collagen deposition. Interestingly, there was no signifi cant difference in collagen 
deposition in the subcutaneous fat depot between the genotypes; this may be partly 
because Mincle expression is not markedly increased in obese subcutaneous fat 
depots, where macrophage infi ltration was not so remarkable. Thus, Mincle-KO 
mice exhibited increased adipose tissue weight with increased adipocyte cell size 
with signifi cant reduction of CLS and reduced adipose tissue fi brosis. 
 We next examined the liver phenotypes of Mincle-KO mice and found that 
hepatic steatosis is markedly attenuated in Mincle-KO mice. Accordingly, liver TG 
content and serum ALT concentrations were signifi cantly reduced in Mincle-KO 
mice. We also examined glucose metabolism and insulin sensitivity by glucose and 
insulin tolerance tests and confi rmed improved glucose metabolism and insulin 
 sensitivity in Mincle-KO mice. 
 During the paracrine interaction between adipocytes and macrophages, saturated 
fatty acids, which are released via the macrophage-induced adipocyte lipolysis, are 
able to induce Mincle in the infi ltrating CLS macrophages through the TLR4/NF-κB 
pathway [ 10 ,  11 ]. Mincle may recognize as-yet-unidentifi ed endogenous ligands 
released from dead adipocytes as a danger signal, thereby stimulating adipose tissue 
fi brosis. In Mincle-KO mice, where adipose tissue fi brosis is attenuated, adipocytes 
can be hypertrophied enough to store lipid, which may reduce ectopic fat accumula-
tion in the liver. Accordingly, our data suggest that Mincle plays a critical role in the 
formation of CLS and adipose tissue fi brosis during the course of obesity, which 
may reduce lipid-storage capacity in adipose tissue and enhance ectopic lipid accu-
mulation [ 11 ]. 
 Summary 
 Our data suggest that CLS and hCLS provide the unique microenvironment where 
dead or dying parenchymal and stromal cells crosstalk in close proximity in vivo 
(Fig.  2 ). In NASH liver, parenchymal hepatocytes, when they are overloaded with 
lipids and thus dead or dying, report their dysfunctional state to the adjacent stromal 
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cells such as macrophages and fi broblasts via multiple danger signals or dying 
 messages. Given that Mincle, when induced in macrophages in CLS, plays a critical 
role in the development of adipose fi brosis, it is tempting to speculate that Mincle is 
also involved in the progression of hepatic fi brosis. Detailed analysis of hCLS may 
provide a clue to discover candidate molecules to be used as biomarkers and/or drug 
targets specifi c for NASH.
 Acknowledgments  We thank the members of the Ogawa laboratory for discussions. Part of this 
study has been supported by the Uehara Memorial Foundation. 
 Fig. 2  Detailed analysis of hCLS helps identify candidate molecules to be used as biomarkers 
and/or drug targets specifi c for NASH 
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